2Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics, 2008, 122 (2) :360-367.
3Jang YC, Arumugan S, Ferguson M, et al. Changes in matrix composition during the growth and regression of human hemangiomas. J Surg Res, 1998,80( 1 ) :9-15.
4Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolnl for severe hemangiomas of infancy. N Engl J Med, 2008, 358(24) : 2649-2651.
5Janowska-Wieczorek A, Majka M, Maquez-Curtis L,et al. Bcr-abl positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia,2002,16 : 1160-1166.
6Gille H, Kowalski J, Yu L, et al. A repressor sequene in the juxtamembrance domain of Flt-1(VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration[J]. EMBO J, 2000, 19(15): 4064-4073.
7Nakopoulou L, Stefanaki K, Panayotopoulou E, et al. Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation[J]. Human Pathology, 2002, 33(9): 863-870.
8Wu L W, Mayo L D, Dunbar J D, et al. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation[J]. J Biol Chem, 2000, 275(7): 5096-5103.
9Veikkola T, Karkkainen M, Claesson-Welsh L, et al. Regulation of angiogenesis via vascular endothelial growth factor receptors[J]. Cancer Res, 2000, 60(2): 203-212.
10Kanno S, Oda N, Abe M, et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells[J]. Oncogene, 2000, 19(17): 2138-2146.
